ICAD Inc
NASDAQ:ICAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biosig Technologies Inc
OTC:BSGM
|
US |
ICAD Inc
PP&E Gross
ICAD Inc
PP&E Gross Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ICAD Inc
NASDAQ:ICAD
|
PP&E Gross
$1.9m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
PP&E Gross
$145.9m
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
PP&E Gross
$121.4m
|
CAGR 3-Years
71%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
PP&E Gross
$22.5m
|
CAGR 3-Years
33%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
PP&E Gross
$64.6m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ICAD Inc
Glance View
iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 136 full-time employees. The firm operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). In the Detection segment, the Company’s solutions include advanced image analysis and workflow solutions enables healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, and a comprehensive range of artificial intelligence and computer aided detection (CAD) systems and workflow solutions for two-dimension(2D) and third dimension (3D) mammography, magnetic resonance imaging (MRI) and computed tomography (CT). In the Therapy segment, the Company offers the Xoft System, an isotope-free cancer treatment platform technology. The Xoft System can be used for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.
See Also
What is ICAD Inc's PP&E Gross?
PP&E Gross
1.9m
USD
Based on the financial report for Mar 31, 2025, ICAD Inc's PP&E Gross amounts to 1.9m USD.
What is ICAD Inc's PP&E Gross growth rate?
PP&E Gross CAGR 10Y
-7%
Over the last year, the PP&E Gross growth was -21%. The average annual PP&E Gross growth rates for ICAD Inc have been 2% over the past three years , -8% over the past five years , and -7% over the past ten years .
